Essential reading for the healthcare business
Remember me:
Skip Navigation LinksHealthInvestor article
Deltex makes loss – but seals NHS Supply Chain deal

Blood monitoring group Deltex Medical remained loss-making last year, but continued to position itself as a major supplier to the NHS.

In results for the year ended 31 December 2011, the company reported an operating loss of £1.4 million – the same as the previous year.

Revenue also remained flat at £6.3 million as the company announced a loss per share of one pence.

However, Deltex chairman Nigel Keen claimed the company “is in an exciting and unique position” after the company also announced its selection, through a tender process, to sell cardiac output monitoring equipment to the NHS in England through NHS Supply Chain.

The deal means NHS hospitals are able to purchase Deltex Medical's products from NHS Supply Chain rather than go through a separate tendering process under EU procurement rules. The agreement covers an initial period of two years, followed by the opportunity to extend for up to a further two years.

“The NHS, the world's largest healthcare provider is actively pursuing the rapid and wide-scale implementation of our products,” said Keen. “We are making considerable advances towards creating similar opportunities in other major healthcare systems around the world.”

In March 2011, the clinical watchdog NICE recommended that Deltex’s CardioQ-ODM product be considered for use in all patients undergoing major and high risk surgery.

Posted on: 07/03/2012

Latest news stories

Melqart Asset Management has taken a 5% stake in private hospital operator Spire Healthcare.
Less than half of the public are aware they can choose where they receive NHS-funded hospital treatment, according to a poll by Populus.
Anchor Hanover has appointed energy, services and regeneration provider Engie as a strategic delivery partner, in a 10-year deal worth £80 million.
Retirement living developer Birchgrove has launched a new rental-only retirement scheme in Sidcup, Southeast London.
The Care Quality Commission has rated domiciliary care provider The Good Care Group as outstanding across the five categories it uses to assess performance.


HealthInvestor blog
With our politicians seemingly absent without leave, the UK desperately needs leadership in policy matters that influence investment decisions

Click here to view the HealthInvestor blog

Singapore’s Pan Pacific Hotel was the venue for HealthInvestor Asia’s February seminar on ‘Expansion strategies for ASEAN healthcare providers’.
A thespian and educator at home in a hazmat suit, with culinary prowess, an eye for improvement and a passion for caring for the elderly
In uncertain times, healthcare real estate remains a steady investment prospect. As the population ages and demand for modern care facilities continues to grow, Kenneth MacKenzie, founder and managing partner of Target Healthcare REIT, tells Marie Cahalane of the importance of a holistic approach to care delivery
Catherine Gooderham highlights some of the opportunities and challenges attracting various investors into a market with guaranteed funding – specialist care
Private equity-backed specialist provider Orbis Education & Care is proving popular with service users, families and commissioners by providing top-quality care in a challenging sector. Rob Munro talks to chief executive Mike Currier about what make this Welsh company such a success and its plans to expand into England

Click here to search all feature articles

Digital technology
The NHS App was supposed to be a gateway for patients to access primary care services and was seen as an opportunity for investors to engage with a health service eager to digitise. Things haven't quite gone to plan. HealthInvestor UK investigates
Read more

Christie + Co

my images


Blockchain is a disruptive force; its entry into the healthcare sector has been gradual, but has the potential to be transformational. Jeremy Bowden considers its implications and applications
Read more